IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 11 analysts with an average price target of $31.34. This is a potential upside of $12.12 (63.06%) from yesterday's end of day stock price of $19.22.

Immunovant 's activity chart (see below) currently has 69 price targets and 86 ratings on display. The stock rating distribution of IMVT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70.85% with an average time for these price targets to be met of 197.43 days.

Highest price target for IMVT is $51, Lowest price target is $36, average price target is $31.34.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 07-Feb-2025. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 45 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$51

$30.64 (150.49%)

$51

5 days ago
(07-Feb-2025)

12/20 (60%)

$30.64 (150.49%)

279

Buy

$45

$24.64 (121.02%)

$48

1 months 24 days ago
(19-Dec-2024)

4/8 (50%)

$19.15 (74.08%)

371

Buy

$36

$15.64 (76.82%)

$40

4 months 2 days ago
(10-Oct-2024)

2/3 (66.67%)

$6.07 (20.28%)

35

Buy

5 months 3 days ago
(09-Sep-2024)

4/5 (80%)

$7.25 (19.21%)

113

Buy

$41

$20.64 (101.38%)

$56

5 months 30 days ago
(13-Aug-2024)

1/5 (20%)

$11.21 (37.63%)

3

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 197.43 days on average for the stock forecasts to be realized with a an average price target met ratio 70.85

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 7 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $36.64

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$13.36

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?